Patch testing in patients treated with systemic immunosuppression and cytokine inhibitors

Contact Dermatitis

Volumn 62, Issue 3, 2010, Pages 165-169

  Wee, Jamie S ^a   White, Jonathan M L ^a   McFadden, John P ^a   White, Ian R ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Cytokine inhibitors; Immunosuppression; Patch testing

Indexed keywords

2 BROMO 2 BROMOMETHYLGLUTARONITRILE; ADALIMUMAB; ALLERGEN; AZATHIOPRINE; BUDESONIDE; COBALT CHLORIDE; CYCLOSPORIN A; DICHROMATE POTASSIUM; DISULFIRAM; ETANERCEPT; FORMALDEHYDE; FRAGRANCE; FUMADERM; GALLIC ACID PROPYL ESTER; GENTAMICIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEOMYCIN; NICKEL SULFATE; OXYBENZONE; PREDNISOLONE; ROSIN; SESQUITERPENE LACTONE; SUNSCREEN; TACROLIMUS; THIRAM; CYCLOSPORIN; CYTOKINE; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID;

ADOLESCENT; ADULT; AGED; ALLERGIC REACTION; ARTHRITIS; ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL ARTICLE; CROHN DISEASE; DERMATITIS; ECZEMA; EVERNIA PRUNASTRI; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; LIVER GRAFT; MALE; PATCH TEST; PSORIASIS; PSORIATIC ARTHRITIS; RELIABILITY; RHEUMATOID ARTHRITIS; SCHOOL CHILD; URTICARIA; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; MIDDLE AGED; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; AZATHIOPRINE; CHILD; CYCLOSPORINE; CYTOKINES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE; MIDDLE AGED; MYCOPHENOLIC ACID; PATCH TESTS; PROSPECTIVE STUDIES; TACROLIMUS; TREATMENT OUTCOME; ANTIBODIES, MONOCLONAL, HUMANIZED;

EID: 77649110000     PISSN: 01051873     EISSN: 16000536     Source Type: Journal    
DOI: 10.1111/j.1600-0536.2009.01695.x     Document Type: Article

References (9)

1. Anveden I, Lindberg M, Andersen K E et al. Oral prednisolone suppresses allergic but not irritant patch test reactions in individuals hypersensitive to nickel. Contact Dermatitis 2004 : 50 : 298 303.
2. Rosmarin D, Bush M, Scheinman P L. Patch testing a patient with allergic contact dermatitis who is taking infliximab. J Am Acad Dermatol 2008 : 59 : 145 147.
3. Rustemeyer T, van Hoogstraten I M W, von Blomberg B M E, Scheper R J. Mechanisms in allergic contact dermatitis. In: Contact Dermatitis, 4th edition, Frosch P J, Menné T, Lepoittevin J-P (eds): Berlin, Heidelberg, Springer-Verlag, 2006 : 11 44.
4. Patel A A, Swerlick R A, McCall C O. Azathioprine in dermatology: the past, the present, and the future. J Am Acad Dermatol 2006 : 55 : 369 389.
5. Madan V, Griffiths C E M. Systemic ciclosporin and tacrolimus in dermatology. Dermatol Ther 2007 : 20 : 239 250.
6. Bangert C A, Costner M I. Methotrexate in dermatology. Dermatol Ther 2007 : 20 : 216 228.
7. Zwerner J, Fiorentino D. Mycophenolate mofetil. Dermatol Ther 2007 : 20 : 229 238.
8. Wakabayashi T, Hu D L, Tagawa Y, Sekikawa K, Iwakura Y, Hanada K, Nakane A. IFN-gamma and TNF-alpha are involved in urushiol-induced contact hypersensitivity in mice. Immunol Cell Biol 2005 : 83 : 18 24.
9. Myers W, Newman M, Katz B, Gottlieb A B. Ability to develop rhus allergic contact dermatitis in a patient with psoriasis receiving etanercept. J Am Acad Dermatol 2006 : 55 : S127 S128.